Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | 775,680 | reported | 13 May 2026 | tx 468+7,813,500−4,961,093 |
| QUEST DIAGNOSTICS INC | 6,260 | reported | 25 May 2021 | tx 7+9,520 |
| Relypsa Inc | 2,250 | reported | 01 Sept 2016 | tx 11+25,500−25,500 |
| ONYX PHARMACEUTICALS INC | 0 | reported | 01 Oct 2013 | tx 46+233,450−213,625 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 May 2026 | EXERCISE | HALOZYME THERAPEUTICS, INC. | 20,000 | 12.07 USD | 10b5-1 |
| 11 May 2026 | SALE | HALOZYME THERAPEUTICS, INC. | 9,725 | 64.63 USD | 10b5-1 |
| 11 May 2026 | SALE | HALOZYME THERAPEUTICS, INC. | 3,575 | 65.46 USD | 10b5-1 |
| 11 May 2026 | SALE | HALOZYME THERAPEUTICS, INC. | 6,700 | 66.33 USD | 10b5-1 |
| 12 May 2026 | EXERCISE | HALOZYME THERAPEUTICS, INC. | 20,000 | 12.07 USD | 10b5-1 |
| 12 May 2026 | SALE | HALOZYME THERAPEUTICS, INC. | 100 | 67.85 USD | 10b5-1anomaly |
| 12 May 2026 | SALE | HALOZYME THERAPEUTICS, INC. | 1,398 | 70.29 USD | 10b5-1 |
| 12 May 2026 | SALE | HALOZYME THERAPEUTICS, INC. | 9,802 | 71.37 USD | 10b5-1 |
| 12 May 2026 | SALE | HALOZYME THERAPEUTICS, INC. | 5,900 | 72.15 USD | 10b5-1 |
| 12 May 2026 | SALE | HALOZYME THERAPEUTICS, INC. | 2,800 | 73.12 USD | 10b5-1 |
| 13 May 2026 | EXERCISE | HALOZYME THERAPEUTICS, INC. | 10,000 | 12.07 USD | 10b5-1 |
| 13 May 2026 | SALE | HALOZYME THERAPEUTICS, INC. | 2,100 | 68.10 USD | 10b5-1 |
| 13 May 2026 | SALE | HALOZYME THERAPEUTICS, INC. | 3,350 | 68.88 USD | 10b5-1 |
| 13 May 2026 | SALE | HALOZYME THERAPEUTICS, INC. | 3,950 | 69.79 USD | 10b5-1 |
| 13 May 2026 | SALE | HALOZYME THERAPEUTICS, INC. | 600 | 70.81 USD | 10b5-1 |
| 11 May 2026 | EXERCISE | HALOZYME THERAPEUTICS, INC. | 20,000 | 12.07 USD | 10b5-1deriv |
| 12 May 2026 | EXERCISE | HALOZYME THERAPEUTICS, INC. | 20,000 | 12.07 USD | 10b5-1deriv |
| 13 May 2026 | EXERCISE | HALOZYME THERAPEUTICS, INC. | 10,000 | 12.07 USD | 10b5-1deriv |
| 04 Mar 2026 | SALE | HALOZYME THERAPEUTICS, INC. | 7,329 | 69.94 USD | |
| 04 Mar 2026 | SALE | HALOZYME THERAPEUTICS, INC. | 2,671 | 70.95 USD | |
| 03 Mar 2026 | EXERCISE | HALOZYME THERAPEUTICS, INC. | 20,000 | 12.07 USD | |
| 03 Mar 2026 | SALE | HALOZYME THERAPEUTICS, INC. | 13,481 | 68.85 USD | |
| 03 Mar 2026 | SALE | HALOZYME THERAPEUTICS, INC. | 6,519 | 69.33 USD | |
| 02 Mar 2026 | SALE | HALOZYME THERAPEUTICS, INC. | 4,100 | 69.20 USD | |
| 02 Mar 2026 | SALE | HALOZYME THERAPEUTICS, INC. | 15,322 | 69.80 USD |